IIT-ISM Dhanbad launches India's first geoarchaeology course
IIT-ISM Dhanbad pioneers India's first geoarchaeology program, blending earth sciences with archaeology for multidisciplinary education and research opportunities.
Category : Search result: Solara Active Pharma Sciences
boAt Active Plus Smart Ring Review: Worth Your Money?
Discover our in-depth review of the boAt Active Plus Smart Ring - an affordable smart wearable that's making waves in India's fitness tech market with impressive features and budget-friendly pricing.
Solara Pharma Q2 Loss: ₹10 Crore Amid Challenges
Solara Active Pharma Sciences faces challenging quarter with ₹10 crore net loss despite revenue growth. Discover the operational challenges and management's recovery strategy.
Sun Pharma Q2 Profit Rises 2.5% to ₹3,118 Crore
India's pharmaceutical giant Sun Pharma reports steady Q2 growth with 9% revenue increase while navigating US market challenges. Key insights from their latest earnings report.
Navin Fluorine Shares Surge 22% in 3 Sessions
Discover why Navin Fluorine International shares skyrocketed 22% in just three trading sessions. Expert analysis reveals the key drivers behind this chemical sector powerhouse's impressive rally and what investors should watch next.
Q2 Results Today: Sun Pharma, Grasim, Britannia Earnings
Market eyes Wednesday's Q2 earnings bonanza as pharma giant Sun Pharma, Grasim Industries, and FMCG major Britannia declare results. Get complete analysis and investor expectations.
AgentForce AI Revolutionizes Life Sciences Engagement in India
Discover how AgentForce's AI-powered platform is reshaping customer engagement in India's life sciences sector, eliminating burnout while boosting productivity by 40%.
3 Hot Stocks: Grasim, Aurobindo Pharma, City Union Bank
Religare Broking's Ajit Mishra reveals 3 promising stocks for short-term gains. Discover technical analysis and price targets for Grasim, Aurobindo Pharma, and City Union Bank in this exclusive market insight.
Hot Stocks: Oil India, Aurobindo Pharma, Latent View Analysis
Get expert stock market insights from Jigar Patel of Anand Rathi as he reveals why Oil India, Aurobindo Pharma, and Latent View Analytics present compelling short-term opportunities for Indian investors.
RIMS Ranchi launches 24/7 emergency cancer care
Rajendra Institute of Medical Sciences revolutionizes cancer treatment in Eastern India with round-the-clock emergency oncology services, ensuring critical care for cancer patients at all hours.
Winter Running: 6 Tips to Stay Active & Injury-Free
Don't let the cold weather derail your fitness goals! Discover practical strategies for staying motivated, warm, and safe while running during winter months.
Winter Running: 6 Tips to Stay Active in Cold
Don't let winter derail your fitness routine! Discover expert-backed strategies to keep running safely and effectively during cold months with this comprehensive guide.
Health Biotech Expands Global Presence at CPhI Frankfurt
Indian biopharmaceutical leader Health Biotech Limited makes waves at CPhI Frankfurt 2025, showcasing innovative products and forging international partnerships to strengthen its global market position.
Niner Pharma Expands R&D with 125 New Peptide Molecules
Chandigarh-based Niner Pharma announces massive R&D expansion with 125 novel peptide molecules targeting wellness and cosmetic innovation, positioning India as global leader in peptide research.
Cipla Shares Fall 4% After Q2 Results
Cipla's stock faced significant pressure after Q2 FY2025 results revealed margin pressures despite revenue growth. Discover the key factors behind the 4% decline and what analysts are saying about the pharmaceutical giant's future prospects.
US Push for Affordable Biotech Drugs: India's Opportunity
Federal health officials are accelerating efforts to bring cheaper biotech drugs to market, potentially transforming treatment access and creating new opportunities for Indian pharmaceutical companies.
India Bans Fraudulent Pharma Licenses in Major Reform
India implements sweeping regulatory reforms to combat fraudulent pharmaceutical manufacturing licenses, enhancing drug safety standards for domestic and international markets including US and EU.
Wembanyama Height: Where He Ranks Among NBA's Tallest
Discover where San Antonio Spurs rookie Victor Wembanyama stands in the height hierarchy of the NBA. Get the complete list of the league's tallest active players and fascinating facts about these basketball giants.
Bengaluru Doctors' PG Course Permissions Delayed
In-service doctors in Bengaluru face career stagnation as delays in PG medical course permissions continue, raising concerns about healthcare workforce development.
ICMR Biomedical & Public Health Fellowship 2024
The Indian Council of Medical Research invites applications for its prestigious Junior Research Fellowship 2024 in biomedical sciences and public health. Discover eligibility, stipend details, and application process.
ASNUVA Invests ₹100Cr in India's Largest Spiritual Hub
ASNUVA announces massive ₹100 crore investment to establish India's premier destination for spiritual products and occult sciences, creating 500+ jobs and revolutionizing the wellness industry.
Mukul Agrawal's ₹200 Cr Pharma Stock Bet Revealed
Discover why prominent investor Mukul Agrawal is betting big on a small-cap pharma company with massive growth potential. Get exclusive insights into his latest portfolio move and what it means for retail investors.
Dr. Reddy's Legacy: Transforming Indian Pharma
Discover how Dr. Anji Reddy's visionary journey from generics to innovative drug research positioned India as a global pharmaceutical powerhouse and continues to inspire future generations.
Harvard University Lockdown: Active Shooter Reported
Breaking: Cambridge police confirm active shooter situation near Harvard University campus. Multiple law enforcement agencies responding as search for suspect continues. Campus on immediate lockdown.
Bangladeshi generic drug slashes rare disease treatment cost by 96%
In a revolutionary healthcare development, Bangladesh's Beximco Pharma launches affordable generic version of lifesaving rare disease drug, dramatically reducing treatment costs from crores to lakhs for patients across South Asia.
Sigachi Q2: Profit Halves, Revenue Down 19%
Sigachi Industries faces turbulent quarter with net profit crashing to ₹10.5 crore amid significant revenue decline. What's behind the pharmaceutical giant's disappointing performance?
Cipla Shares Fall 3% Despite Eli Lilly Weight Loss Drug Deal
Cipla's stock faces unexpected pressure despite securing rights to manufacture and distribute Eli Lilly's revolutionary weight loss drug Mounjaro in India. Discover why investors remain cautious.
Cipla-Eli Lilly deal brings weight loss drugs to India
Indian pharmaceutical giant Cipla announces landmark deal with Eli Lilly to manufacture and distribute popular weight loss medications Mounjaro and Zepbound in India under different brand names.
Aurobindo Pharma Expands to Chile with New Subsidiary
Indian pharma giant Aurobindo Pharma establishes new subsidiary in Chile, marking strategic expansion across South American markets with focus on branded prescriptions and over-the-counter medicines.
India's ODI Run Machines: Active Players Dominating Cricket
Discover which active Indian cricketers are rewriting record books with their phenomenal ODI run-scoring feats. From seasoned veterans to emerging talents, we break down the batting heroes shaping India's cricket future.
Page 1 of 2